Quality of care for patients with inflammatory bowel disease in East China

Table 1 Characteristics of patients with CD or UC

Characteristics	CD (n = 71)	UC (n = 106)
Sex (male/female)	41/30	56/50
Age (yr) [mean (range)]	35 (13-70)	45 (15-80)
Disease duration (yr) [mean (range)]	5.3 (0.5-14)	5.8 (0.5-23)
Smoker/non-smoker	17/54	26/80
Disease severity
Mild	13	53
Moderate	38	37
Severe	20	16
Previous surgery	34	4

Table 2 Distribution of CD and UC

Disease location	n
Crohn’s disease (71)
Small intestine	37
Colon	6
Ileocolon	27
Upper gastrointestinal	1
Ulcerative colitis (106)
Distal colitis	35
Left-sided colitis	22
Extensive colitis	47
Missing information	2

Table 3 Suboptimal dose used in treatment of CD and UC

Clinical parameters	Proportion (%)
Suboptimal dose of aminosalicylate
Crohn's disease	27/68 (39.7)
Ulcerative colitis	0/106 (0.00)
Failure to use topical therapy	26/57 (45.6)
Failure to use corticosteroid	10/36 (27.8)
Failure to use immunomodulatory agents	41/51 (80.4)
Suboptimal dose of AZA	4/7 (57.1)

Table 4 Suboptimal dose of aminosalicylate and location of CD

Location of CD	Suboptimal dose (n)	Optimal dose (n)
Small intestines	19	17
Colon	2	4
Ileocolon	6	20

^aP = 0.019: A significantly higher incidence of suboptimal dose in CD patients with small intestine involved only.